Sintomas de depressão nos pacientes com câncer de cabeça e pescoço em tratamento radioterápico: um estudo prospectivo by Paula, Juliana Maria de et al.
Original ArticleRev.  Latino-Am. Enfermagem
2012 Mar.-Apr.;20(2):362-8
www.eerp.usp.br/rlae
Corresponding Author: 
Juliana Maria de Paula
Rua Mário Lamonato, 49
Jardim Morumbi
CEP: 14680-000, Jardinópolis, SP, Brasil
E-mail: jm_paula@hotmail.com
Symptoms of depression in patients with cancer of the head and neck 
undergoing radiotherapy treatment: a prospective study
Juliana Maria de Paula1
Helena Megumi Sonobe2
Adriana Cristina Nicolussi3
Márcia Maria Fontão Zago4
Namie Okino Sawada4
This study aimed to investigate the frequency of symptoms of depression in patients with 
cancer of the head and neck undergoing radiotherapy treatment, in the initial, middle and final 
stages of the treatment. This is a prospective exploratory quantitative study of 41 patients with 
head and neck cancer, undergoing radiotherapy treatment in the Oncology Outpatient Clinic 
of the Beneficência Portuguese Hospital of Ribeirão Preto. Data were collected through the 
Beck Depression Inventory instrument, and analyzed quantitatively by means of the Statistical 
Package for the Social Sciences. Symptoms of dysphoria were found to increase throughout the 
treatment, as well as the number of patients with depression. The results show the importance 
for the healthcare professionals to detect the prevalence and the levels of the symptoms of 
depression, since these symptoms tend to increase and may lead to consequences such as a lack 
of adherence to treatment and a decrease in the quality of life of these patients.
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Sintomas de depressão nos pacientes com câncer de cabeça e pescoço 
em tratamento radioterápico: um estudo prospectivo
Este estudo teve como objetivo identificar a frequência dos sintomas de depressão nos 
pacientes com câncer de cabeça e pescoço, em tratamento radioterápico, no início, meio 
e final do tratamento. Trata-se de estudo exploratório prospectivo, com abordagem 
quantitativa, de 41 pacientes com câncer de cabeça e pescoço, em tratamento 
radioterápico no Ambulatório de Oncologia do Hospital Beneficência Portuguesa 
de Ribeirão Preto. Os dados foram coletados por meio do instrumento inventário de 
depressão de Beck, e analisados de modo quantitativo, por meio do programa Statistical 
Package of Social Science. Conclui-se que os sintomas de disforia aumentaram ao 
longo do tratamento, assim como o número de pacientes com depressão. Os resultados 
mostram a importância de os profissionais da saúde detectarem a prevalência e os níveis 
dos sintomas de depressão, uma vez que esses sintomas tendem a aumentar, podendo 
levar a consequências como falta de aderência ao tratamento e diminuição da qualidade 
de vida desses pacientes.
Descritores: Radioterapia; Depressão; Neoplasias de Cabeça e Pescoço.
Síntomas del depresión en los pacientes con cáncer de cabeza y cuello 
en tratamiento radioterápico: un estudio prospectivo
El objetivo de este estudio fue investigar la frecuencia de los síntomas de depresión en 
pacientes con cáncer de cabeza y cuello en el principio, medio y final del tratamiento 
radioterápico. Se trata de un estudio prospectivo, exploratorio y cuantitativo realizado 
con 41 pacientes con cáncer de cabeza y cuello en tratamiento de radioterapia en la 
Clínica de Oncología del Hospital Beneficencia Portuguesa de Ribeirão Preto. Los 
datos fueron recolectados a través del Inventario de Depresión de Beck y analizados 
cuantitativamente en el programa Statistical Package of Social Science. Como resultados 
se obtuvo los síntomas de disforia aumentaron durante el tratamiento, así como el 
número de pacientes con depresión. Los resultados muestran la importancia de los 
profesionales de salud en detectar los niveles y la prevalencia de síntomas de depresión, 
ya que estos síntomas tienden a aumentar y pueden llevar a consecuencias como la falta 
de adherencia al tratamiento y disminución de la calidad de vida de los pacientes.
Descriptores: Radioterapia; Depresión; Neoplasias de Cabeza y Cuello.
Introduction
The cancers of the head and neck represent the 6th 
most common of all cancers. The estimation of cancer 
of the oral cavity, for the year 2010, according to the 
Ministry of Health(1) is 10,330 new cases in men and 
3,790 in women. As head and neck surgery involves 
major resections, functional and aesthetic mutilations 
occur that impact in the daily life of patients. Another 
common treatment in this type of cancer is radiotherapy 
and chemotherapy which are used as adjuvants in order 
to inhibit metastasis and to improve the survival rate(2). 
The cancer treatments cause various physical and 
emotional collateral effects that impact in the daily life of 
the patient. Of all the symptoms anxiety and depression 
are the most prevalent psychological symptoms of 
cancer patients, with prevalence rate from 13 to 54%(3-4). 
According to these authors the variation is due to the 
different forms of measurement and heterogeneous 
samples.
The literature review(5) showed that depression 
is the most common psychiatric disorder in patients 
with cancer, with a prevalence between 22 and 29% 
depending on the location of the tumor, clinical stage, 
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pain, functional and physical performance, and the 
existence of social support. Regarding head and neck 
cancer, a study(6) was highlighted that estimated the 
prevalence of depression between 6 and 15% in contrast 
with rates of up to 40% found in studies in the 1980’s. 
A study carried out in the screening sector of the Head 
and Neck Surgery Service of the INCA(7), found high 
levels of depressive symptoms in patients with head and 
neck cancer with a positive correlation in relation to the 
presence of pain. That is, the symptoms of depression 
present in patients with head and neck cancer may be 
related, among other causes, to the discomfort caused 
by the pain. In one study(5) the authors reported the 
difficulty in diagnosing depression in cancer patients, 
highlighting that it often goes undiagnosed due to 
lack of time to investigate the emotional issues, costs 
associated with the treatment, and mental health 
specialists and the oncologist working separately. 
Consequently, the depression is not treated, which leads 
to increased suffering in these patients, worsening the 
manifestation of cancer and impairing adherence to the 
treatment, leading to increased mortality. In another 
study(8) the authors conducted a systematic literature 
review on depression in elderly patients with cancer 
and highlighted the high prevalence of depressive 
disorders in cancer patients, especially the elderly, and 
the very low number of investigations into this. They 
found the rate of major depression to be moderate and 
that of minor depression to be high, and that they are 
accompanied by subliminal forms of depression that are 
at risk of not being recognized and not treated.
The person with cancer needs to adjust to their 
new identity as an oncological patient and needs to deal 
with the collateral effects of the radiotherapy, which 
can make the individual feel impotent in the face of 
their new condition(9). It is very important to precisely 
evaluate the presence of symptoms of depression during 
the radiotherapy, in order to mitigate them and ensure 
good adherence of the patient to the treatment. Given 
the above, this study aimed to identify the frequency of 
symptoms of depression in patients with cancer of the 
head and neck undergoing radiotherapy treatment, in 
the initial, middle and final stages of the treatment.
Methods
This is an exploratory-descriptive, prospective, 
study with a quantitative approach. The exploratory-
descriptive study, carried out between February 2009 
and July 2010, was performed with the application 
of the Beck Depression Inventory, adapted in Brazil 
by Goreinstein(10). The study was conducted in the 
Specialized Oncology Center (CEON) of Ribeirão Preto 
- São Paulo. The CEON is part of the Beneficiência 
Portuguesa Hospital, where outpatient care is performed, 
through consultations, examinations, treatment and 
monitoring of adult patients with cancer originating from 
the Brazilian National Health System (SUS), from health 
insurance companies and the private sector of the city of 
Ribeirão Preto and the surrounding region.
The sample was comprised of 41 patients with head 
and neck cancer, undergoing radiotherapy treatment, 
who agreed to participate in the study and signed the 
terms of free prior informed consent. The inclusion 
criteria were: older than 18 years, diagnosed with cancer 
of the head and neck, treated at CEON, and in treatment 
at the time. Patients with other diagnoses and/or other 
cancers were excluded, as were those who had some 
mental deficit that could hinder the comprehension and/
or participation in the study and interviews. The research 
project was approved by a Research Ethics Committee 
and the anonymity of the patients was maintained 
according to the CONEP Resolution No. 196/96(11).
For the categorization of the patient data, an 
identification questionnaire was constructed to collect 
the socio-demographic data containing the variables: 
gender, age, marital status, origin, profession/
occupation, level of education and religion; clinical and 
therapeutic data; diagnosis; performance and type of 
surgery. The application of the instrument occurred during 
the first cycle of radiation therapy (Baseline), which 
evaluated the presence of symptoms of depression. The 
instrument was administered at the initiation (baseline), 
middle (approximately the 15th session) and termination 
of treatment (after the 30th session), to evaluate the 
presence of and changes in the symptoms of depression 
over the course of the radiotherapy treatment. All the 
patients in this sample completed the BDI at three times, 
with no loss of subjects due to death or prematurely 
ending their participation in the study. For the reading of 
the Beck Depression Inventory instrument, the criteria 
below were followed:
Beck Depression Inventory - Scale with 21 items 
that evaluate: 1) depressed mood, 2) pessimism, 3) 
sense of failure, 4) loss of satisfaction, 5) sense of guilt, 
6) sense of punishment, 7) self-rancor (hatred, disgust), 
8) self-accusation, 9) suicidal ideation, 10) crying, 
11) irritability, 12) social isolation, 13) indecision, 14) 
altered body image, 15) inhibition for work, 16) sleep 
abnormalities, 17) fatigue, 18) loss of appetite, 19) 
weight loss, 20) somatic concerns, and 21) loss of libido.
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The scale is graduated in responses of 0 to 3, where 
zero is the absence of the symptom and 3 the maximum 
presence of the symptom. The minimum score is 0 
and the maximum is 63. For the analysis of the cutoff 
point, a score of 0 to 15 was related to the absence 
of depression, 16 to 20 to dysphoria and from 21 to 
63 to depression. For the data analysis, the Statistical 
Package for the Social Sciences (SPSS - version 15.0) 
was used and the Cronbach’s Alpha test of internal 
consistency to test the reliability of the instrument. 
Descriptive statistical analysis was performed for the 
socio demographic and clinical analysis of the BDI.
Results
To test the internal consistency of the BDI in this 
sample, the Cronbach’s alpha test was applied with the 
result α=0.91, demonstrating that the instrument is 
reliable with this sample. Table 1 shows the demographic 
characteristics of the 41 patients with head and neck 
cancer undergoing radiotherapy, it was found that the 
majority of the patients came from the city of Ribeirão 
Preto (46.3%) and the surrounding region (36.5%), 
were predominantly male (85.4%) and over 50 years of 
age (82.9%).
Characteristics N %
Origin 
Ribeirão Preto 19 46.3
Ribeirão Preto Region 15 37
Others 7 17
Total 41 100
State
São Paulo 41 100
Total 41 100
Age 
30 | — 50 7 17.1
50 | — 70 20 48.8
Table 1 - Descriptive statistics of the sociodemographic 
characteristics
(continue...)
Table 1 - (continuation)
Characteristics N %
70 | — 90 14 34.1
Total 41 100
Gender
Female 6 14.6
Male 35 85.4
Total 41 100
Profession
Work in the home 6 14.6
Retired 17 41.5
Security/Guard/Porter 5 12.2
Carpenter/mason/electrician 4 9.7
Farm worker 9 22.0
Total 41 100
Religion
Catholic 34 82.9
Evangelical 4 9.8
No religion 3 7.3
Total 41 100
Table 2 - Descriptive statistics of the clinical characteristics
Characteristics N %
Diagnosis
Parotid CA 1 2.4
 Laryngeal CA 10 24.4
Hypopharynx/mouth/neck SCC 30 73.2
Total 41 100
Underwent surgery
Yes 24 58.5
No 17 41.5
Total 41 100
Underwent chemotherapy
Yes 22 53.7
No 19 46.3
Total 41 100
Table 2 shows that the predominant diagnosis was 
squamous cell carcinoma of the hypopharynx, mouth 
and neck (73.1%) and that the majority had undergone 
surgery (58.5%) and chemotherapy (53.6%).
Table 3 - Results of the BDI at the first, second and third application
Beck Depression Inventory (values) 1
st Application
Frequency (%)
2nd Application
Frequency (%)
3rd Application
Frequency (%)
≤15 33 (80.5%) 30 (73.2%) 28 (68.3%)
16 to 20 05 (12.2%) 07 (17.1%) 09 (21.9%)
21 to 63 03 (7.3%) 04 (9.7%) 04 (9.8%)
Total 41 (100%) 41 (100%) 41 (100%)
Table 3 shows that the symptoms of dysphoria 
increased throughout the treatment. At the initiation 
of the treatment only 12.1% of the patients had these 
symptoms and at the termination 21.9% of patients had 
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symptoms of dysphoria. The proportion of patients with 
depression at the initiation was equal to 7.3% and 9.7% 
at the termination.
In order to check whether there was a statistically 
significant difference between the first and third 
application or the second and third application of the 
BDI, the Student’s t-test for paired samples was 
performed with the results shown in Table 4.
Table 4 - Results of the Student’s t-test for the BDI 
between the first and third applications, and the second 
and third applications
BDI Mean Standard deviation
Student’s 
t-test p
BDI1 - BDI3 -2.878 4.160 -4.160 0.000
BDI2 - BDI3 -0.0707 3.716 1.219 0.230
Table 4 shows that there was a statistically significant 
difference between the first and third applications, 
while between the second and third application there 
was no statistically significant difference, revealing that 
the changes in symptoms of dysphoria and depression 
were significant when considering the initiation and 
termination of treatment
Discussion
The socio-demographic characterization is 
consistent with the literature that demonstrates the 
higher incidence of head and neck cancer in males of 
the over 50 age group. The risk factors for cancer of the 
head and neck are associated with mutagenic and/or 
carcinogenic agents, originating from the environment, 
such as smoking, alcohol consumption, and genetic 
factors, which lead to a high incidence of this type of 
cancer in various countries Over 90% of the patients 
with head and neck cancer have a history of smoking 
and alcohol consumption. The inherent conditions of the 
individual, such as genetic susceptibility, may also alter 
this incidence, because not every smoker or alcohol 
user has the same risk of developing a tumor. Genetic 
susceptibility factors can be genetic polymorphism 
of enzymes that are able to metabolize carcinogenic 
agents; deficiency in the DNA repair mechanisms; the 
genetic characteristics related to sex and ethnic group; 
and familial susceptibility to cancer syndromes(12).
In Brazil, patients with head and neck cancer have 
specific particularities that differ from neoplasms of other 
sites; the majority of these patients are in the over 50 
age group and present associated diseases due to their 
poor general condition, as a result of changes caused 
by the disease itself and the socio-economic situation, 
along with numerous paraneoplastic syndromes(13). The 
National Cancer Institute highlighted laryngeal cancer 
as one of the most common to affect the head and neck 
region, representing about 25% of the tumors that 
affect this area and 2% of all malignant diseases(1).
The high incidence of laryngeal cancer in our study 
(24.4%) resembles that also described in a study which 
presented the incidence of cancer of the largest cities 
in the State of São Paulo, especially the city of Ribeirão 
Preto which presented laryngeal cancer as one of the 
most common, with an incidence rate of 23.1%(14). The 
sample of the present study included patients from the 
region of Ribeirão Preto (82.8%) with the occupation 
of farm workers (21.9%). These results relate to the 
type of work in the region of Ribeirao Preto, where the 
monoculture of sugarcane offers an area of work for cane 
cutters, among which the consumption of high doses 
of liquor and tobacco is common, two risk factors for 
cancer of the head and neck. A study(15) developed in the 
same region, also found similar results with respect to 
the labor occupation, demonstrating the predominance 
of retirees, followed by the categories farm worker, 
driver, guard, mason and electrician.
Depression, which in 2004 was the third leading 
cause of disease worldwide and a leader of disability 
in the high-income countries, can also adversely affect 
the course and outcome of chronic conditions such as 
cancer, diabetes and obesity(16). The frequent association 
between depression and clinical illnesses, leads to a 
worse evolution both for the psychiatric conditions as 
well as for the clinical diseases, with lower adherence 
to the therapeutic guidelines as well as increased rates 
of morbidity and mortality(17). In oncology, depression 
is associated with a decline in survival and adherence 
to treatment leading to a worse prognosis. Estimates 
indicate that approximately 10 to 25% of cancer patients 
present a major depressive disorder(18). In the present 
study, from the middle of treatment, 17% of patients 
were found to have dysphoria, increasing to 21.9% at 
the termination of the treatment. It was also found that 
9.75% of the patients had the presence of symptoms 
of depression at the termination of treatment. These 
data corroborate those of another study that found a 
10.2% rate of depression in patients with breast cancer 
undergoing radiotherapy(19). The frequency of symptoms 
of depression found in the present study was 7.3% at 
the initiation of radiotherapy and 9.7% in the middle and 
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at the termination of the treatment, with a statistically 
significant difference; in another study(20) the frequency 
of depressive symptoms was similar, at 7%.
The serious collateral effects of the chemotherapy 
and radiotherapy treatments may be responsible for the 
increase in the symptoms of depression over time(21). 
The results of the present study highlight the need 
to evaluate the presence of symptoms of anxiety and 
depression throughout the radiotherapy treatment, 
as these symptoms tend to increase and may lead 
to consequences such as a lack of adherence to the 
treatment, a lower rate of survival and a decrease in the 
quality of life of the patients with head and neck cancer.
Conclusions
The socio-demographic characterization found 
in this study is consistent with the literature that 
demonstrates the higher incidence of head and neck 
cancer in males of the over 50 age group. Symptoms 
of depression are common in patients with cancer 
undergoing radiotherapy treatment. The data of the 
present study showed that there was an increase in 
symptoms throughout the treatment, the symptoms 
of dysphoria increased from 12.1% at the initiation of 
the treatment to 21.9% at the termination, whereas 
depression increased from 7.3% at the initiation of the 
treatment to 9.7% at the termination, with significant 
results between the first and third applications of the 
BDI.
Patients with head and neck cancer, undergoing 
oncological treatment, may develop symptoms of 
depression due to various factors related to the cancer 
itself and to the treatment. They may experience 
functional changes, such as difficulty breathing, 
swallowing, and impaired verbal communication, leading 
to social isolation and the adherence to treatment may be 
adversely affected. The use of instruments, such as the 
BDI, in the quotidian practice with oncological patients 
undergoing radiotherapy treatment is important, so 
that the treatment becomes more effective since the 
symptoms of depression can be identified and evaluated 
throughout the course of treatment by the healthcare 
team in the non-psychiatric medical context, allowing 
the healthcare team to evaluate the mental health issues 
and propose interventions according to the needs of the 
patient, in order to improve their well-being and Quality 
of Life. The results of this study showed the importance 
of the healthcare professionals detecting the frequency 
and levels of depressive symptoms and planning actions 
that minimize these symptoms in order to improve the 
Quality of Life of patients with cancer of the head and 
neck undergoing radiotherapy treatment.
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